Clinical Trial Update: Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Ixiaro as a booster following mouse-brain derived Japanese encephalitis vaccines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• IXIARO (inactivated Japanese encephalitis vaccine)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Japanese Encephalitis | Phase 3 | Status: COMPLETED